Latest Board Renewal News

The week was split between big earnings reactions and small-cap rocks-and-rigs rallies. Pro Medicus sank despite record numbers, while a handful of explorers jumped on fresh discoveries and policy wins.

Takeover chatter lit up Pepper Money, while Identitii ran hard after a regulator stepped in. At the other end, AMP slid despite higher profit, as investors weighed leadership change and legal costs.

ASX Limited has posted a solid 8.3% increase in net profit for the half-year ending December 2025, while announcing a reduced dividend payout and the planned departure of its CEO. The company is navigating regulatory scrutiny and investing heavily in technology upgrades.

AMP Limited reported a 20.8% rise in underlying net profit after tax for 2025, driven by growth in wealth platforms and investments, alongside a planned CEO transition and pending class action settlements.

A handful of healthcare names did the heavy lifting this week, driven by FDA wins, guideline upgrades, and big shifts in sales and cashflow. The flip side: several clinical-stage stocks fell hard as investors stayed picky about near-term proof and funding.

Conico Ltd has finalised a major recapitalisation and corporate restructure, positioning itself for renewed exploration with a focus on scandium amid strong market demand. The company plans an extensive drilling program at its Mt Thirsty project to expand its scandium resource.

Aland Equity Group Limited has completed significant capital raisings and board restructuring while navigating a challenging quarter for its flagship Growth Fund. The company is positioning itself for expansion into property funds management.

IODM Limited has reported a standout Q2 FY26 with record cash receipts driven by strong UK education sector growth and strategic board renewal.

Galilee Energy has secured the Zydeco Gas Project in Louisiana and raised $6.5 million to fast-track development, marking a pivotal shift towards becoming a mid-tier US gas producer.

Microba Life Sciences reports a 90% year-on-year increase in core microbiome test volumes, driving a 123% rise in core testing revenue to $2.1 million, while advancing clinical adoption and cost efficiencies.

IGO Limited reports a robust quarter with improved safety, higher spodumene production and prices at Greenbushes, successful commissioning of CGP3, and solid performance at Nova. Despite challenges at Kwinana refinery, the group’s underlying EBITDA and cash flow strengthened.

Altech Batteries has reported a significant technical milestone with its Silumina Anodes™ technology achieving 88.5% capacity retention after 500 cycles, alongside a $6 million capital raise and a strategic board renewal focused on commercialisation.